Precision Wealth Strategies LLC Has $363,000 Holdings in DaVita Inc. (NYSE:DVA)

Precision Wealth Strategies LLC lowered its stake in shares of DaVita Inc. (NYSE:DVA) by 18.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 2,427 shares of the company’s stock after selling 561 shares during the period. Precision Wealth Strategies LLC’s holdings in DaVita were worth $363,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. MML Investors Services LLC boosted its position in shares of DaVita by 1.3% during the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after buying an additional 68 shares during the last quarter. Exchange Traded Concepts LLC boosted its holdings in DaVita by 8.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after acquiring an additional 68 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of DaVita by 1.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock worth $776,000 after acquiring an additional 70 shares in the last quarter. Impact Partnership Wealth LLC raised its holdings in shares of DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after purchasing an additional 70 shares during the last quarter. Finally, Contravisory Investment Management Inc. lifted its position in shares of DaVita by 1.2% during the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after purchasing an additional 73 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Stock Down 0.2 %

DVA opened at $176.16 on Friday. DaVita Inc. has a twelve month low of $107.74 and a twelve month high of $179.60. The company’s 50-day moving average price is $159.72 and its two-hundred day moving average price is $155.17. The stock has a market cap of $14.44 billion, a price-to-earnings ratio of 19.00, a PEG ratio of 0.85 and a beta of 0.92. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DVA shares. Barclays upped their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Truist Financial upped their target price on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.